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The aim of this study was to analyze the effects of a 4-week-long consumption of glucomannan-enriched, aronia juice-based
supplement on anthropometric parameters,membrane fatty acid profile, and status of antioxidant enzymes in erythrocytes obtained
from postmenopausal women with abdominal obesity. Twenty women aged 45–65 with a mean body mass index (BMI) of 36.1 ±
4.4 kg/m2 and waist circumference of 104.8 ± 10.1 cm were enrolled. Participants were instructed to consume 100mL of supplement
per day as part of their regular diet. A significant increase in the content of n-3 (𝑃 < 0.05) polyunsaturated fatty acids in membrane
phospholipids was observed, with a marked increase in the level of docosahexaenoic fatty acid (𝑃 < 0.05). Accordingly, a decrease
in the n-6 and n-3 fatty acids ratio was observed (𝑃 < 0.05).The observed effects were accompanied with an increase in glutathione
peroxidase activity (𝑃 < 0.05). Values for BMI (𝑃 < 0.001), waist circumference (𝑃 < 0.001), and systolic blood pressure (𝑃 < 0.05)
were significantly lower after the intervention. The obtained results indicate a positive impact of tested supplement on cellular
oxidative damage, blood pressure, and anthropometric indices of obesity.
1. Introduction
Obesity is a serious public health problem related to oxidative
stress with or without additional diseases, such as insulin
resistance, diabetes, polycystic ovary syndrome, and car-
diovascular diseases (CVD) [1–3]. Visceral or upper body
obesity has been associated with an increased incidence of
cardiovascular events. The mechanism in which obesity and
development of CVD are rela ted includes metabolic disor-
ders such as dyslipidemia and hyperinsulinemia, disrupted
homeostasis, and inflammation [4]. A direct association of
obesity with oxidative stress was rationalised by the infil-
tration of macrophages into adipose tissue and their over-
production of reactive oxygen species (ROS) and cytokines.
Additionally, the expansion of fat mass leads to hypoxia
and the consequent apoptosis of adipocytes which serves
as a trigger for macrophage infiltration [5]. A disbalance in
H+ levels related to hypoxia has been reported to inhibit
mitochondrial production of energy and lead to an incom-
plete reduction of oxygen and ROS formation [6]. In the state
of abdominal obesity, accumulated fat was characterized with
disturbed oxidative status accompanied with an increased
expression of NAD(P)H oxidase and decreased activity of
antioxidant enzymes [7]. It has been shown that central
obesity correlates with a decrease in total antioxidant capacity
(TAC) independent of age, smoking status, blood pressure,
blood lipid, and glucose levels. An association of TAC with
body mass index (BMI) and waist circumference was found
to be more pronounced in women than in men [8].
Indicators of lipid peroxidation levels are the most com-
mon group of indices used to evaluate the individual’s oxida-
tive status [9]. Besides the common measurement of lipid
peroxidation products, such as malondialdehyde (MDA) and
isoprostanes, a relative concentration of polyunsaturated fatty
acids (PUFAs) has been suggested as an indirect marker of
membrane lipid peroxidation [10, 11]. Due to high content
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of unsaturated bonds as the main site of free radicals
attack, PUFAs are fatty acids susceptible to oxidative damage.
Since biological membranes are the first line of cell contact
with extracellular substances, including free radicals [12],
it is of special importance to determine their fatty acid
profile and status of PUFAs. Recent studies revealed that
polyphenol-rich plant extracts protect biological membranes
from oxidative damage by scavenging free radicals in the
medium. Furthermore, their protective effects were related
to the incorporation of polyphenols in the outer hydrophilic
part of the membrane phospholipid bilayer [12, 13]. This way
polyphenols could ensure the usual physicochemical charac-
teristics of the membrane and provide suitable structure and
functions.
Chokeberry (Aronia melanocarpa) is found to be a rich
source of polyphenols, especially anthocyanins present as
different forms of cyanidin-glycosides. Numerous health
promoting effects of chokeberry, related to its strong antiox-
idant activity, have been revealed [14]. Beneficial effects
of long-term consumption of chokeberry juice and other
aronia products on metabolic parameters including lipid
profiles, fasting plasma glucose, and blood pressure levels
have been reported [15–17]. In vitro investigations showed an
increase in antioxidant defense and decrease in ROS levels
after incubation with chokeberry active compounds [18, 19].
However, data on the effects of chokeberry on oxidative
status and antioxidant defense in vivo are limited. Still, some
studies report the stimulation of erythrocytes antioxidant
enzymes as a result of chokeberry consumption in humans
[15, 20].
Intake of foods rich in dietary fibers has been recom-
mended in order to promote health and prevent cardio-
vascular and other chronic diseases development. This is
based on their positive impact on weight management and
traditional risk factors, such as total and LDL cholesterol
[21, 22]. Potential role of dietary fibers in defence against
oxidative stress has been rarely studied.
The aim of our study is to investigate the effects of a
4-week-long consumption of glucomannan-enriched, aronia
juice-based dietary supplement on anthropometric parame-
ters, membrane fatty acid profile, and status of antioxidant
enzymes in erythrocytes obtained from female subjects with
abdominal obesity.
2. Material and Methods
2.1. Subjects and StudyDesign. Thestudywas approved by the
Ethical Committee of the Medical Clinical Center in Zemun
(Belgrade, Serbia) and has been undertaken according to the
Helsinki Declaration. All subjects gave written informed con-
sent prior to the enrolment. Twenty postmenopausal women
aged 45–65 with abdominal obesity, defined according to
Adult Treatment Panel III [23], as a waist circumference
greater than 88 cm, were enrolled. They were instructed to
consume 100mL of glucomannan-enriched, aronia juice-
based supplement daily for 4 weeks as part of their regular
diet. Exclusion criteria were the presence of chronic diseases
treated with drugs, a diagnosis of diabetes, food allergy,
dietary supplementation three months preceding the study,
or intolerance to the supplement’s ingredients.
During the course of the study subjects were instructed
to continue with their regular diet. The dietary pattern,
assessed by applying 3-month food frequency questionnaire
(FFQ), for most of the subjects was defined as “moderately
unhealthy,” as characterized by high intake of redmeat, added
fat, processed food, and low to medium habitual intake of
fruits, vegetables, soy, and fish. All subjects were sedentary
(<1 h/wk of physical activity), free of alcohol consumption,
and nonsmokers with relatively high energy intake.
Blood samples were obtained at the baseline and at
the end of the consumption period, after an overnight
fast. Erythrocytes were isolated and stored at −80∘C for
further analysis of antioxidant enzymes status and fatty acid
profile. Routine biochemical parameters were determined
immediately after blood sampling. Additionally, anthropo-
metric measurements, including blood pressure level, were
performed during both study visits.
2.2. Glucomannan-Enriched, Aronia Juice-Based Supplement.
The intervention drink was donated from Nutrika d.o.o.,
Belgrade, Serbia. It was prepared from pure aronia juice
enriched with 2 g of stable glucomannan fibers (Luralean,
Shimizu, Japan). The total quantity of aronia juice provided
to the participants was from the same batch. Participants
were instructed to keep the beverage in the refrigerator after
opening. The content of total phenolics and anthocyanins
was determined in our laboratory by previously described
methods [24, 25] and obtained values were 586.7 ± 3.3mg
gallic acid equivalent per 100mL and 15.3 ± 0.2mg cyanidin-
3-glucoside equivalent per 100mL, respectively.
2.3. Sample Collection and Analysis. Venous blood was
collected between 8 and 10 pm after the overnight fast
into sample tubes for serum and EDTA evacuated tubes
at two time points: baseline and the end of a 4-week-long
supplement consumption. Lipid status and glucose levels
were determined from serum, on the same day the samples
were collected, using clinical chemistry analyzer (Cobas e411,
Roche Diagnostics, Basel, Switzerland) and Roche Diagnos-
tics Kits according to the manufacturer’s instructions. Sam-
ples from EDTA tubes were centrifuged to separate the red
blood cells from plasma. Packed erythrocytes were washed
out three times with cold isotonic saline, divided into aliquots
and stored at −80∘C for further analysis. Anthropometric
parameters, including systolic (SBP) and diastolic blood
pressure (DBP) levels, were determined at the beginning and
the end of the study.
2.4. Fatty Acid Extraction and Analysis. First, lipids were
extracted from 0.5mL of packed erythrocytes with a mixture
of chloroform : isopropanol (7 : 11) according to the method
described previously [26]. Phospholipids were then separated
from other lipid subclasses on a silica thin-layer chromatog-
raphy plate using the solvent system of petroleum ether,
diethyl ether, and glacial acetic acid (87 : 12 : 1, by volume).
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Afterwards, direct transesterification of fatty acids was car-
ried out according to the previous procedure with slight
modifications [27]. The hexane extracts were evaporated
under a stream of nitrogen to complete dryness. The residue
was dissolved in 10 𝜇L of hexane and 1 𝜇L was injected into
the chromatograph.
Methyl esters of fatty acids were analyzed by gas-liquid
chromatography in a Shimadzu chromatograph GC 2014
equipped with a flame ionization detector on a Rtx 2330
column (60m × 0.25mmID, film thickness 0.2 𝜇m, Restek,
Bellefonte, PA). Adequate separation was obtained over a
50min period with an initial temperature of 140∘C held for
5 minutes. The temperature was then increased to 220∘C
at a rate of 3∘C/min and held in the final temperature for
20 minutes. The identification of fatty acid methyl esters
was made by comparing peak retention times with standard
mixtures (PUFA-2 and/or 37 FAMEsmix, Supelco, Bellefonte,
PA). Finally, the content of fatty acids from 16:0 through
22:6n-3 was expressed as a percent of total fatty acids
identified.
The percentage of total saturated fatty acids (SFAs)
was calculated as the sum of the percentages of C16:0
and C18:0, while the percentage of monounsaturated fatty
acids (MUFAs) was determined from C16:1n-7, C18:1n-9, and
C18:1n-7 percentages. The percentage of total PUFAs was
calculated from the percentages of the individual polyun-
saturated long-chain fatty acids C18:2n-6, C20:3n-6, C20:4n-
6, C22:4n-6, C20:5n-3, C22:5n-3, and C22:6n-3. The average
degree of fatty acid unsaturation (the unsaturation index) was
calculated as the average number of double bonds per fatty
acid residue multiplied by 100, as previously suggested [28].
2.5. Antioxidant Enzyme Analysis. The activity of superoxide
dismutase (SOD) in red blood cells was measured using
a commercial kit (Randox-Ransod, Cat no. SD 125, UK).
The determination of SOD activity was based on superox-
ide anion (O
2
−∙) production in the xanthine-xanthine oxi-
dase system and its further reaction with 2-(4-iodophenyl)-
3-(4-nitrophenol)-phenyltetrazolium chloride (INT) which
resulted in forming red formazan dye. SOD from samples
catalyzed the dismutation of superoxide anion and led to
changes in the absorbance, which were monitored contin-
uously at 505 nm and 37∘C for 3min. The units of SOD
activity were calculated from these changes with the use of
the standard curvemade with known amounts of the purified
enzyme. Erythrocyte glutathione peroxidase (GPx) activ-
ity was determined according to the previously described
method [29] with use of commercial kit (Randox-Ransel,
Cat no. RS 505, UK). In the presence of cumene hydroper-
oxide GPx catalyzed the formation of oxidized glutathione,
which was further reduced by glutathione reductase with the
consumption of coenzyme NADPH+H+. Based on this, the
activity of GPx was measured by monitoring the decrease in
absorbance due to disappearance of NADPH+H+ at 340 nm
and 37∘C.The activity of catalase (CAT) was measured by the
method Aebi described [30]. The determination was based





the formation of water and molecular oxygen. A decrease in
Table 1: Anthropometric and biochemical parameters.
Parameter Baseline End point 𝑃 value
Number 20
Age (years) 53.0 ± 5.4
Body weight (kg) 96.1 ± 12.3 93.9 ± 10.7 0.075
BMI (kg/m2) 36.1 ± 4.4 35.0 ± 4.0 <0.001
Waist circumference
(cm) 104.8 ± 10.1 100.6 ± 9.2 <0.001
SBP (mmHg) 127.6 ± 16.9 116.4 ± 16.1 <0.05
DBP (mmHg) 83.5 ± 9.9 78.4 ± 9.1 0.076
Total cholesterol
(mmol/L) 6.28 ± 1.41 5.92 ± 1.06 0.164
HDL cholesterol
(mmol/L) 1.26 ± 0.32 1.18 ± 0.33 <0.05
LDL cholesterol
(mmol/L) 4.05 ± 1.32 3.80 ± 1.0 0.164
Triglycerides
(mmol/L) 2.05 ± 0.89 2.05 ± 1.23 0.717
Glucose (mmol/L) 6.45 ± 2.01 6.0 ± 1.38 0.137
Data are presented as mean ± SD.






concentration was measured spectrophotometrically
at 230 nm during 3 minutes and the change of absorbance
was used for the determination of CAT activity.The activities
of antioxidant enzymes were expressed in U/gHb. Cyan-
methemoglobin method with Drabkin’s reagent based on
spectrophotometry at 540 nm was applied for the assessment
of hemoglobin concentration in red blood cells [31].
2.6. Statistical Analysis. Data are shown as mean values ±
standard deviation (SD) and comparisons were performed
by paired samples 𝑡-test. Prior to comparisons, the normality
of variables distribution was tested by Shapiro-Wilk test.
Analyses were performed using the SPSS software (ver.
15.0; Chicago, IL) and 𝑃 values ≤ 0.05 indicated statistical
significance.
3. Results
3.1. Characteristics of the Subjects. The general character-
istics of the study group are presented in Table 1. Twenty
postmenopausal women with a mean age of 53.0 ± 5.4
and an average BMI of 36.1 ± 4.4 kg/m2 and waist cir-
cumference of 104.8 ± 10.1 cm were included. Values of
measured biochemical parameters were not changed, except
for HDL cholesterol which was slightly decreased. At the
end of the consumption period significant decrease in waist
circumference (𝑃 < 0.001), as an indicator of abdominal
obesity, and BMI (𝑃 < 0.001) was recorded. Furthermore,
blood pressure level was also evaluated and a lowering effect
was noted with a significant change in the case of SBP (𝑃 <
0.05).
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3.2. Effects on the Fatty Acid Profile. A significant decrease
(𝑃 < 0.05) was shown in the case ofMUFAs, theC18:1n-9, and
n-6/n-3 ratio, while an increase was observed in the case of
C22:6n-3 (𝑃 < 0.05), n-3 PUFAs (𝑃 < 0.05), and unsaturation
index (𝑃 = 0.05). Also, the percentage of total PUFA was
lower at the end of the study compared to the baseline, but this
difference did not reach statistical significance (𝑃 = 0.062).
Similarly, an insignificant decrease in the amount of total
SFA and C16:0 (𝑃 = 0.066) was noted. These findings are
presented in Table 2.
3.3. Effects on Antioxidant Enzymes. Effects of aronia juice-
based supplement consumption on antioxidant enzymes in
red blood cells are shown in Figure 1. The analysis revealed a
statistically significant increase in GPx activity (43.75 ± 9.67
versus 48.39 ± 9.93; 𝑃 = 0.05). However, values of SOD
activity did not differ at the end of consumption period
compared to the baseline (2237.66±1035.23 versus 2115.15±
747.83U/gHb). Additionally, no impact on CAT activity was
recorded (68.28 ± 12.90 versus 69.39 ± 10.99 kU/gHb).
4. Discussion
Obesity is associated with increased inflammation, elevated
blood lipids and glucose levels, and insensitivity to insulin,
which contribute to the initiation and propagation of cardio-
vascular and other chronic diseases.This ismore pronounced
in the case of low antioxidant defense and poor antioxidant
intake. For these reasons, it would be of special importance
to develop interventional strategies for decreasing oxidative
stress and incidence of diseases in overweight and obese
subjects [2].
In the present study, we investigated the effects of 4-
week-long glucomannan-enriched, aronia juice-based sup-
plementation on erythrocytes fatty acids profile in subjects
with abdominal obesity. As a result, an increase in the levels
of total (𝑃 = 0.062) and n-3 (𝑃 < 0.05) PUFAs, followed with
an increase in unsaturation index (𝑃 = 0.05), was observed.
An increase in total n-3 PUFAs was most probably based on
the increase in relative amount of docosahexaenoic (DHA;
C22:6n-3) fatty acid (𝑃 < 0.05). PUFAs are considered to
be the most prone compounds to oxidation with their double
bonds as the sites of interaction with free radicals. Our find-
ings demonstrate oxidative damage attenuation manifested
in an increase of average unsaturation of fatty acids in the
cell membrane. Additionally, the observed results suggest
potential beneficial effects of aronia juice-based supplement
consumption in the prevention of cardiovascular and other
obesity associated diseases. It has been shown that the
amount of n-3 fatty acids in erythrocyte membranes is nega-
tively associated with cardiovascular disease risk, incidence
of rheumatoid arthritis, and metabolic syndrome [32, 33].
DHA, as themost important individual n-3 fatty acid, showed
the potential to lower blood pressure, through the increase
in endothelium release of nitric oxide [34]. Following the
increase in n-3 fatty acids content, a significant decrease
(𝑃 < 0.05) in relative n-6/n-3 ratio was observed at the end
of the consumption period. A high n-6/n-3 ratio has been
Table 2: Membrane fatty acid profile in erythrocytes.
Fatty acid (%) Baseline End point 𝑃 value
Saturated 42.33 ± 5.20 40.58 ± 3.51 0.125
16:0 22.22 ± 4.54 20.24 ± 2.45 0.066
18:0 19.96 ± 2.61 20.34 ± 2.53 0.655
Monounsaturated 15.89 ± 2.10 14.79 ± 1.55 <0.05
16:1n-7 0.31 ± 0.16 0.34 ± 0.14 0.483
18:1n-9 13.99 ± 1.94 12.94 ± 1.44 <0.05
18:1n-7 1.58 ± 0.42 1.51 ± 0.24 0.414
n-6 polyunsaturated 35.86 ± 5.72 37.58 ± 3.16 0.108
18:2n-6 12.50 ± 1.35 12.34 ± 1.67 0.591
20:3n-6 2.20 ± 0.57 2.09 ± 0.56 0.557
20:4n-6 17.13 ± 4.27 18.28 ± 2.49 0.090
22:4n-6 4.48 ± 1.26 4.74 ± 0.83 0.273
n-3 polyunsaturated 5.91 ± 1.59 7.05 ± 2.16 <0.05
20:5n-3 0.32 ± 0.19 0.44 ± 0.47 0.171
22:5n-3 1.71 ± 0.41 1.87 ± 0.26 0.227
22:6n-3 3.89 ± 1.24 4.74 ± 1.60 <0.05
Total polyunsaturated 41.77 ± 6.69 44.63 ± 3.89 0.062
n-6/n-3 6.51 ± 1.96 5.72 ± 1.48 <0.05
Unsaturation index 169.62 ± 25.42 178.81 ± 16.60 0.05
Data are presented as mean ± SD.
associated with inflammation and pathogenesis of chronic
diseases, while its reducing resulted in attenuation of diseases
development [35]. The levels of oleic acid (C18:1n-9) and
total MUFAs in erythrocyte phospholipids were significantly
decreased after the supplementation (𝑃 < 0.05). It is possible
thatMUFAs proportion, alongwith no significant decrease in
SFA content, was lowered as a compensation to the increase
of PUFAs.
Several studies have evaluated the physicochemical char-
acteristics of erythrocyte membranes depending on BMI and
revealed a statistically significant lower content of n-3 fatty
acids and higher n-3/n-6 ratio in obese women compared
to those with a normal BMI. Erythrocyte membranes were
found to be particularly susceptible to peroxidation in obese
subjects, which is accompaniedwith a decrease in the amount
of PUFAs and altered fluidity and structure of membrane
[36, 37]. This way, deformed red blood cells exert lower
diffusion capacity, which could lead to insufficient tissue
oxygenation. Hypoxia of cardiovascular and endothelial cells
in particular further contributes to an increasing incidence of
all cardiovascular pathologies associated with obesity [36].
The observed effects on fatty acid profiles of membrane
phospholipids were accompanied with a significant increase
of GPx activity in erythrocytes (𝑃 < 0.05) at the end of
intervention period compared to baseline. No significant
changes were noted in the activities of the other two evaluated
antioxidant enzymes, SOD and CAT. Our findings were in
accordance with the improvement in GPx status, shown
in patients with hypercholesterolemia supplemented with
aronia anthocyanins for 1 month [38]. Broncel et al. [15]
found a significant increase in both SOD and GPx activities







































Figure 1: Activities of antioxidant enzymes at the baseline and end point of the study. Data are presented as mean ± SD. GPx = glutathione
peroxidase; SOD = superoxide dismutase; CAT = catalase.
after a 2-month-long consumption of chokeberry extract
in subjects with metabolic syndrome. Additionally, they
reported a significant decrease in the activity of CAT.
Detected increase of average degree of membrane fatty
acid unsaturation indicates protective effects of glucoman-
nan-enriched, aronia juice-based supplement on oxidative
damage of membrane lipids. In our previous work, we
found a significant correlation between increase in GPX
activity and relative amount of total PUFAs in erythrocytes
membranes of healthy female volunteers who consumed
polyphenol-rich aronia juice for 12 weeks [39]. Based on
these findings and results obtained from presented study,
we suggest indirect antioxidant effects of aronia juice as
potential mechanism for observed alterations in membrane
fatty acid composition.This could be explainedwith presence
of polyphenols as main bioactive compounds in aronia juice.
Indirect effects of polyphenols against oxidative stress were
previously suggested, based on their ability to stimulate
activity of antioxidant enzymes and modulate cell signaling
pathways and gene expression [40]. Additionally, protective
effects of polyphenols against membrane lipid oxidation were
associated with their interaction with the lipid phase of ery-
throcyte membrane and incorporation in outer hydrophilic
part [12, 13]. As far as authors are aware data on direct effects
of glucomannan intake on oxidative status or membrane
fatty acid profile in humans are lacking. Limited data include
the effects of glucomannan to decrease ROS generation in
human neutrophils in vitro [41]. Thus, we hypothesize that
the antioxidant effects of tested supplement are mainly the
result of aronia juice polyphenols action. However, puta-
tive antioxidant effects of glucomannan could be mediated
through effects on postprandial load of glucose and lipids
shownpreviously [42] and subsequent raise of oxidative stress
accompanied with the similar effects of polyphenols [43].
Consumption of glucomannan-enriched, aronia juice-
based supplement exerted effects on anthropometric param-
eters as well. A significant decrease in BMI (𝑃 < 0.001)
and waist circumference (𝑃 < 0.001) was shown at the
end of the intervention period compared to baseline. Relying
on the literature data, observed beneficial effects on weight
management could be attributed to both aronia juice and
glucomannan. After reviewing the data from available human
intervention studies, EFSAPanel onDietetic Products, Nutri-
tion, and Allergies revealed that glucomannan could have
effects on body weight loss in the context of an energy-
restricted diet [42]. This was explained as a reduced appetite
achievedwhen glucomannan is consumed as a preload before
meals. According to EFSA, in order to obtain claimed effects,
at least 3 g of glucomannan per day should be administered.
However, the reported effects of glucomannan consumption
on weight management are not consistent. A recently con-
ducted meta-analysis of 8 randomized clinical trials revealed
no statistically significant effects of glucomannan on weight
loss in comparison to a placebo [44]. On the other hand, data
on the possible effects of chokeberry, and its products, on
weight loss in human intervention studies are limited. Some
authors suggest that polyphenol-rich foods could contribute
to the management of weight control due to their beneficial
effects on insulin sensitivity, adipogenesis, and inflammatory
pathways. Accordingly, they reported suppressive effects of
aronia extracts on weight gain in rats fed for 6 weeks with
a high fructose diet with or without the extract added
[45].
Four-week-long consumption of glucomannan-enriched,
aronia juice-based supplement exerted lowering effects on
blood pressure, with a significant decrease observed in SBP
levels (𝑃 < 0.05). Observed hypotensive effects could be
associated with weight reduction, since obesity is considered
to be risk factor for hypertension and CVD development.
Additionally, previous studies reported beneficial effects of
aronia products on blood pressure level. Both SBP and
DBP were significantly lowered in subjects with metabolic
syndrome who consumed aronia extract regularly for two
months [15]. Similarly, a decrease in blood pressure level,
which was significant for DBP, was observed after a 6-week-
long consumption of chokeberry juice in men with mild
hypercholesterolemia [17]. Recent studies reported vasorelax-
ing properties of polyphenols which are most likely based
on the stimulation of nitric oxide synthesis in vascular
endothelium [46, 47]. In addition, blood pressure lowering
effects of aronia products were considered to be an out-
come of other activities as well, including the inhibition of
angiotensin I-converting enzyme and antioxidative effects
[48].
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The role of obesity in the pathogenesis of cardiovascular
and other chronic diseases relies mostly on its association
with other risk factors, including elevated blood glucose and
lipid levels, inflammation, and insulin resistance. Deleterious
role of obesity on human health is even more pronounced
in case of low antioxidant capacity and low intake of dietary
antioxidants [2, 4]. Results obtained in this study indicate
a positive impact of glucomannan-enriched, aronia juice-
based supplement consumption on cellular redox status of
subjects with abdominal obesity, shown by the stimulation
of GPx activity and alteration in membrane fatty acids.
Beneficial effects also include an improvement in anthro-
pometric parameters and blood pressure. Thus, the overall
effects of a tested product containing both dietary fibers
and antioxidants-rich aronia juice are putatively a result of
their synergistic effects on several indices of obesity, and
related risk factors. Accordingly it could be suggested as
a supplement to the optimal diet in obese subjects, as an
effective dietary measure in the prevention of cardiovascular
and other chronic diseases related to obesity. Although final
conclusions are limited due to the low number of study
participants and the lack of proper control this study shows a
potential of a novel product and favors its further research.
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